TORONTO, September 22, 2021 (GLOBE NEWSWIRE) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Society” Where “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the webcast link for the Annual General Meeting of Shareholders of Blueberries Medical Corp. (the” AGM ” or the “meeting”).
The general assembly will take place on Wednesday, September 29e, 2021 at 1 p.m. EST.
Given that in Ontario, proof of vaccination is required for all shareholders who wish to attend the AGM in person, the company has decided to proactively address the unprecedented public health impact of COVID-19. and provincial and federal public guidelines. meetings, shareholders and proxyholders are only invited to attend the Meeting online by following the instructions below. The COVID-19 virus is causing unprecedented social and economic disruption and the company wants to ensure that no one is put at unnecessary risk. In addition, in order for the Company to mitigate potential risks to the health and safety of shareholders, employees and the community, the number of persons authorized to participate in the Meeting will be strictly limited.
In order to streamline the meeting process, the Company urges all shareholders to vote by proxy prior to the meeting in accordance with the instructions set out in the proxy, and to listen to the meeting via live conference and web presentation details. provided. below:
Date and time: Wednesday, September 29e, 2021, at 1 p.m. (Toronto time)
Instructions for team meeting:
Microsoft Teams link to join the meeting
https://teams.microsoft.com/l/meetup-join/19%3ameeting_OGVhZmUzZDgtNTMzMy00ZTQ1LWI3N2QtODU0NGE2OTdlMzlh%40thread.v2/0?context=%7b%22Tid%921% 3aid%2280% 327d-4d0c-b9b8-641624cb58ca% 22% 7d
Complete information on how registered and beneficial shareholders can vote prior to the Meeting is available in Blueberries’ management information circular, also filed on SEDAR.
Participants should log in approximately 5-10 minutes before the scheduled start time. Shareholders who log into the Meeting via the Teams virtual meeting details above will not be able to vote on matters submitted to the Meeting.
The deadline to vote your proxy before the meeting is 1:00 p.m. Eastern Time, Monday, September 27, 2021.
The streaming connection of the virtual teams will allow shareholders to listen to the debates and ask questions verbally via the virtual session.
Following the formal deliberations of the AGM, management will provide an update and company presentation.
About Blueberries Medical Corp.
Blueberries is a Latin American licensed producer of premium, naturally grown cannabis with its main operations conveniently located in the Savannah of Bogotá, central Colombia. The company is managed by a specialized team with exclusive expertise in the fields of agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries is fully licensed for the cultivation, production, national distribution and international export of medical cannabis based on CBD and THC in Colombia. . The combination of cutting-edge scientific expertise, agricultural benefits and distribution agreements from Blueberries has positioned the company to become a leading international supplier of medicinal grade cannabis oil extracts naturally grown, processed and standardized and related products.
Additional information about the Company is available at www.blueberriesmed.com. For more information please contact:
Jose Forero, President, Latin America Operations
Phone. : +57 310 345 8808
Guillermo Rodriguez, CFO of Blueberries Medical Corp.
Phone. : +54 911 6015 2227
Caution regarding forward-looking information
This press release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as of the date of this press release. Any statement that involves discussions regarding predictions, expectations, beliefs, plans, projections, goals, assumptions, future events or performance, “anticipates” or “does not anticipate”, “plans”, “budget”, “planned”, “Foresees”, “estimates”, “believes” or “, events or results” may “or” could “,” would “,” could “or” could “be considered to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this press release, forward-looking statements relate to, among others: the closing of the proposed transactions and the achievement of milestones in 2019 as planned, or not at all, the ability to expand distribution networks, the ability to expand and to modernize the Company’s cultivation facilities in Colombia, internal expectations, expectations regarding the Company’s ability to access new Latin American and international markets, the ability to attract and retain new and future clients expansion plans, including the development of cultivation, production, industrialization and marketing of cannabis for commercial and scientific purposes. purposes.
These forward-looking statements are based on reasonable assumptions and estimates of the management of the Company at the time these statements were made. Actual future results may differ materially, as forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the results, performance or achievements. futures expressed or implied by these forward-looking statements. These factors include, but are not limited to: fluctuations in general macroeconomic conditions; fluctuations in the securities markets; expectations regarding the size of the Colombian and international medical cannabis market and changing consumption patterns; the Company’s ability to successfully achieve its business objectives; expansion plans; political and social uncertainties; failure to obtain adequate insurance to cover risks and dangers; and the presence of laws and regulations that may impose restrictions on the cultivation, production, distribution and sale of cannabis and cannabis-related products in Colombia, Argentina and elsewhere; and employee relations. Although the forward-looking statements contained in this press release are based on what the management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with these. forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or expected. Readers should not place undue reliance on the forward-looking statements and information contained in this press release. The Company assumes no obligation to update forward-looking statements of beliefs, opinions, projections or other factors, if they change, except as required by law.
Additional information concerning the Company and other risks and uncertainties relating to the activities of the Company are contained under the heading “Risk Factors” in the Company’s registration statement dated January 31, 2019 filed on its issuer profile. on SEDAR at www.sedar.com.
No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained in this document.